Related Experiment Videos
Mutations of the human PTEN gene
1Department of Medical Genetics, University of Poitiers, Poitiers, France. bonneau@chu-poitiers.fr
Human Mutation
|August 3, 2000
Summary
The tumor suppressor gene PTEN (phosphatase and tensin homolog deleted on chromosome ten) regulates cell growth. PTEN mutations are linked to Cowden and Bannayan-Riley-Ruvalcaba syndromes and are common in endometrial cancers and glioblastomas.
Area of Science:
- Molecular biology
- Genetics
- Oncology
Background:
- PTEN (phosphatase and tensin homolog deleted on chromosome ten) is a tumor suppressor gene.
- It regulates cell proliferation and survival by controlling the phosphoinositide 3-kinase signaling pathway.
- Germline PTEN mutations are associated with Cowden disease and Bannayan-Riley-Ruvalcaba syndrome.
Purpose of the Study:
- To review germline and somatic PTEN mutations.
- To identify mutation hotspots and patterns.
- To understand PTEN's role in cancer development.
Main Methods:
- Literature review of reported germline PTEN mutations (110 cases).
- Review of somatic PTEN mutations in primary tumors and metastasis (332 cases).
- Analysis of mutation distribution, hotspots, and types.
Main Results:
- Germline mutations are scattered but exon 5 is a hotspot; CpG dinucleotides are mutation-prone.
- Somatic PTEN mutations are frequent in endometrial carcinomas and glioblastomas.
- Most somatic mutations lead to PTEN protein inactivation; CpG dinucleotides are also mutation-prone in somatic mutations.
Conclusions:
- PTEN mutations play a significant role in tumor predisposition and development.
- Specific cancer types like endometrial carcinomas and glioblastomas show a high prevalence of somatic PTEN mutations.
- Understanding PTEN mutation patterns aids in cancer research and potential therapeutic strategies.